houston semaglutide The Cost of in Benefits of Semaglutide GLP-1 for

Instant Brightening Effect Enhances radiance and leaves skin looking visibly refreshed

Trasatti C, Spears R, Gutmann JL, Opperman LA

However, among the common gastrointestinal side effectsincluding nausea, vomiting, diarrhea, and constipationnausea consistently appears as the most frequently reported symptom

(MOV 27950 kb) Three distinct microglial morphologies generated in response to compression injury (download MOV A representative time lapse showing the three distinct microglial morphologies was captured in a CX3CR1 mouse beginning 5 min following compression injury

2.4% placebo) 86.4% of participants lost at least 5% of body weight 69.1% lost at least 10% 50.5% lost at least 15% STEP 3 (Wadden et al., 2021, JAMA ): Combined with intensive behavioral therapy Average weight loss: 16.0% over 68 weeks Demonstrated that lifestyle support amplifies medication effects STEP 5 (Garvey et al., 2022, Nature Medicine ): Two-year duration study Average weight loss: 15.2% maintained over 104 weeks Demonstrated sustained effectiveness with continued use Retatrutide Clinical Trial Results Phase 2 Trial (Jastreboff et al., 2023, NEJM ): 338 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Multiple dose groups (1 mg, 4 mg, 8 mg, 12 mg weekly) Results at the 12 mg dose: Average weight loss: 24.2% in 48 weeks 100% of participants lost at least 5% of body weight 93% lost at least 10% 83% lost at least 15% 63% lost at least 20% Weight loss trajectory had not plateaued at study end Comprehensive Comparison Table Side Effects Comparison Both medications share similar gastrointestinal side effect profiles because they both activate GLP-1 receptors

Clinical trial group members Afrnio Ferreira Evangelista, Camila Oliveira Valente, Carolina Th Macedo, Cassio Santana Meira, Crislaine Gomes da Silva, Danielle Devequi Gomes Nunes, Emanuelle de Souza Santos, Katharine Valria Saraiva Hodel, Leticia de Alencar Pereira Rodrigues, Patrcia Kauanna Fonseca Damasceno, Rodrigo Souza Conceio, and Vincius Pinto Costa Rocha (Institute of Health Technologies ITSSENAI CIMATEC)